Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3
K. A. Papp, K. B. Gordon, R. G. Langley, M. G. Lebwohl, A. B. Gottlieb, S. Rastogi, R. Pillai, R. J. Israel
Dive into the research topics of 'Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3'. Together they form a unique fingerprint.